Gossamer Bio Stock Net Income
| GOSS Stock | USD 2.73 0.00 0.00% |
As of the 26th of January, Gossamer Bio retains the Market Risk Adjusted Performance of 0.2861, downside deviation of 5.04, and Risk Adjusted Performance of 0.0638. Gossamer Bio technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Gossamer Bio variance and potential upside to decide if Gossamer Bio is priced fairly, providing market reflects its last-minute price of 2.73 per share. Please also validate Gossamer Bio total risk alpha, which is currently at (0.10) to confirm the company can sustain itself at a future point.
Gossamer Bio Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 14.7008 | Revenue | Earnings Share (0.69) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -50.9 M | -53.4 M | |
| Net Loss | -206.4 M | -216.8 M | |
| Net Loss | -50.9 M | -53.4 M | |
| Net Loss | (0.29) | (0.30) | |
| Net Income Per E B T | 0.91 | 0.81 |
Gossamer | Net Income | Build AI portfolio with Gossamer Stock |
Latest Gossamer Bio's Net Income Growth Pattern
Below is the plot of the Net Income of Gossamer Bio over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Gossamer Bio financial statement analysis. It represents the amount of money remaining after all of Gossamer Bio operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Gossamer Bio's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Gossamer Bio's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (56.53 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Gossamer Net Income Regression Statistics
| Arithmetic Mean | (81,324,715) | |
| Coefficient Of Variation | (118.85) | |
| Mean Deviation | 85,458,554 | |
| Median | (50,875,200) | |
| Standard Deviation | 96,655,167 | |
| Sample Variance | 9342.2T | |
| Range | 243.3M | |
| R-Value | (0.55) | |
| Mean Square Error | 6945T | |
| R-Squared | 0.30 | |
| Significance | 0.02 | |
| Slope | (10,537,052) | |
| Total Sum of Squares | 149475.5T |
Gossamer Net Income History
Other Fundumenentals of Gossamer Bio
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Gossamer Bio Net Income component correlations
Gossamer Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Gossamer Bio is extremely important. It helps to project a fair market value of Gossamer Stock properly, considering its historical fundamentals such as Net Income. Since Gossamer Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Gossamer Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Gossamer Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gossamer Bio. If investors know Gossamer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gossamer Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.69) | Revenue Per Share | Quarterly Revenue Growth 0.402 | Return On Assets | Return On Equity |
The market value of Gossamer Bio is measured differently than its book value, which is the value of Gossamer that is recorded on the company's balance sheet. Investors also form their own opinion of Gossamer Bio's value that differs from its market value or its book value, called intrinsic value, which is Gossamer Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gossamer Bio's market value can be influenced by many factors that don't directly affect Gossamer Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gossamer Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Gossamer Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gossamer Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Gossamer Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Gossamer Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Gossamer Bio.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in Gossamer Bio on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Gossamer Bio or generate 0.0% return on investment in Gossamer Bio over 90 days. Gossamer Bio is related to or competes with Kalvista Pharmaceuticals, 4D Molecular, Olema Pharmaceuticals, Ventyx Biosciences, Lexicon Pharmaceuticals, Rigel Pharmaceuticals, and Prothena Plc. Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and comme... More
Gossamer Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Gossamer Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Gossamer Bio upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.04 | |||
| Information Ratio | 0.0605 | |||
| Maximum Drawdown | 31.39 | |||
| Value At Risk | (6.57) | |||
| Potential Upside | 9.59 |
Gossamer Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gossamer Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Gossamer Bio's standard deviation. In reality, there are many statistical measures that can use Gossamer Bio historical prices to predict the future Gossamer Bio's volatility.| Risk Adjusted Performance | 0.0638 | |||
| Jensen Alpha | 0.291 | |||
| Total Risk Alpha | (0.10) | |||
| Sortino Ratio | 0.0632 | |||
| Treynor Ratio | 0.2761 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Gossamer Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Gossamer Bio January 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0638 | |||
| Market Risk Adjusted Performance | 0.2861 | |||
| Mean Deviation | 3.94 | |||
| Semi Deviation | 4.51 | |||
| Downside Deviation | 5.04 | |||
| Coefficient Of Variation | 1327.04 | |||
| Standard Deviation | 5.26 | |||
| Variance | 27.72 | |||
| Information Ratio | 0.0605 | |||
| Jensen Alpha | 0.291 | |||
| Total Risk Alpha | (0.10) | |||
| Sortino Ratio | 0.0632 | |||
| Treynor Ratio | 0.2761 | |||
| Maximum Drawdown | 31.39 | |||
| Value At Risk | (6.57) | |||
| Potential Upside | 9.59 | |||
| Downside Variance | 25.37 | |||
| Semi Variance | 20.36 | |||
| Expected Short fall | (4.10) | |||
| Skewness | 0.6723 | |||
| Kurtosis | 1.81 |
Gossamer Bio Backtested Returns
Gossamer Bio appears to be unstable, given 3 months investment horizon. Gossamer Bio holds Efficiency (Sharpe) Ratio of 0.0691, which attests that the entity had a 0.0691 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Gossamer Bio, which you can use to evaluate the volatility of the firm. Please utilize Gossamer Bio's Risk Adjusted Performance of 0.0638, market risk adjusted performance of 0.2861, and Downside Deviation of 5.04 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Gossamer Bio holds a performance score of 5. The company retains a Market Volatility (i.e., Beta) of 1.4, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Gossamer Bio will likely underperform. Please check Gossamer Bio's potential upside, as well as the relationship between the accumulation distribution and relative strength index , to make a quick decision on whether Gossamer Bio's current trending patterns will revert.
Auto-correlation | -0.88 |
Excellent reverse predictability
Gossamer Bio has excellent reverse predictability. Overlapping area represents the amount of predictability between Gossamer Bio time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Gossamer Bio price movement. The serial correlation of -0.88 indicates that approximately 88.0% of current Gossamer Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.88 | |
| Spearman Rank Test | -0.69 | |
| Residual Average | 0.0 | |
| Price Variance | 0.19 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Gossamer Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Gossamer Bio reported net income of (56.53 Million). This is 116.56% lower than that of the Biotechnology sector and 180.7% lower than that of the Health Care industry. The net income for all United States stocks is 109.9% higher than that of the company.
Gossamer Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Gossamer Bio's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Gossamer Bio could also be used in its relative valuation, which is a method of valuing Gossamer Bio by comparing valuation metrics of similar companies.Gossamer Bio is currently under evaluation in net income category among its peers.
Gossamer Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Gossamer Bio from analyzing Gossamer Bio's financial statements. These drivers represent accounts that assess Gossamer Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Gossamer Bio's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 846.5M | 183.5M | 205.8M | 204.6M | 235.3M | 223.6M | |
| Enterprise Value | 848.3M | 297.3M | 386.2M | 361.5M | 415.7M | 610.9M |
Gossamer Bio ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Gossamer Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Gossamer Bio's managers, analysts, and investors.Environmental | Governance | Social |
Gossamer Bio Institutional Holders
Institutional Holdings refers to the ownership stake in Gossamer Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Gossamer Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Gossamer Bio's value.| Shares | Hillhouse Capital Advisors, Ltd. | 2025-06-30 | 5 M | Geode Capital Management, Llc | 2025-06-30 | 4.6 M | Alyeska Investment Group, L.p. | 2025-06-30 | 4.5 M | Ci Private Wealth Llc | 2025-06-30 | 3.7 M | Monaco Asset Management | 2025-06-30 | 3.5 M | Opaleye Management Inc | 2025-06-30 | 3.5 M | Rock Springs Capital Management Lp | 2025-06-30 | 3.3 M | Renaissance Technologies Corp | 2025-06-30 | 2.7 M | State Street Corp | 2025-06-30 | 2.5 M | Octagon Capital Advisors Lp | 2025-06-30 | 18.4 M | Nea Management Company, Llc | 2025-06-30 | 18.1 M |
Gossamer Fundamentals
| Return On Equity | -7.83 | ||||
| Return On Asset | -0.34 | ||||
| Operating Margin | (3.13) % | ||||
| Current Valuation | 647.58 M | ||||
| Shares Outstanding | 231.46 M | ||||
| Shares Owned By Insiders | 4.10 % | ||||
| Shares Owned By Institutions | 78.50 % | ||||
| Number Of Shares Shorted | 24.11 M | ||||
| Price To Earning | (4.61) X | ||||
| Price To Book | 2.66 X | ||||
| Price To Sales | 14.19 X | ||||
| Revenue | 114.7 M | ||||
| Gross Profit | 44.05 M | ||||
| EBITDA | (39.97 M) | ||||
| Net Income | (56.53 M) | ||||
| Cash And Equivalents | 304.38 M | ||||
| Cash Per Share | 3.29 X | ||||
| Total Debt | 202.88 M | ||||
| Debt To Equity | 3.86 % | ||||
| Current Ratio | 5.93 X | ||||
| Book Value Per Share | (0.36) X | ||||
| Cash Flow From Operations | (3.47 M) | ||||
| Short Ratio | 5.49 X | ||||
| Earnings Per Share | (0.69) X | ||||
| Price To Earnings To Growth | (0.63) X | ||||
| Target Price | 9.5 | ||||
| Number Of Employees | 144 | ||||
| Beta | 1.93 | ||||
| Market Capitalization | 624.93 M | ||||
| Total Asset | 315.29 M | ||||
| Retained Earnings | (1.27 B) | ||||
| Working Capital | 264.88 M | ||||
| Current Asset | 441.63 M | ||||
| Current Liabilities | 39.84 M | ||||
| Net Asset | 315.29 M |
About Gossamer Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Gossamer Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gossamer Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gossamer Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Gossamer Stock Analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.